Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Clinical Trial to Evaluate Safety and Efficacy of BZ371A in a Gel Applied in Patients That Performed Radical Prostatectomy

NCT05558007 is registered in ClinicalTrials.gov with Biozeus Biopharmaceutical S.A. as lead sponsor.

NCT NCT05558007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05558007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Clinical Trial to Evaluate Safety and Efficacy of BZ371A in a Gel Applied in Patients That Performed Radical Prostatectomy
Lead sponsor
Biozeus Biopharmaceutical S.A.
Phase
Phase 2
Overall status
Recruiting
Start date
November 22, 2023
Completion date
January 31, 2025
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction, erectile dysfunction following radical prostatectomy, prostate cancer, radical prostatectomy